Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-2.92%
-2.08%
+9.79%
-19.01%
-3.34%
PRTA
Prothena Corporation
$4.59
Chart
$9.3 (-50.65%)
$15.27 (-69.94%)
$15.48 (-70.35%)
$20.37 (-77.47%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.92%
-2.08%
+9.79%
-19.01%
-3.34%
PRTA
Prothena Corporation
Current Price
$4.59
Login to view Prothena Corporation (PRTA) recommendation from the last 90 days from financial news and social media.
Chart
$9.3 (-50.65%)
$15.27 (-69.94%)
$15.48 (-70.35%)
$20.37 (-77.47%)
PRTA Latest Headlines
BofA cuts Prothena stock rating slashes target to $4.
Wed May 28, 2025
Why Is Prothena Stock Trading Lower On Tuesday?. ) released data from the Phase 3 AFFIRM-AL clinical trial evaluating birtamimab in patients with AL .AL (amyloid light-chain) amyloidosis isa systemic disease where abnormal proteins called amyloid fibrils accumulate in various organs.It’.s the most common .The Phase 3 AFFIRM-AL trial enrolled 207 newly diagnosed patients. Birtamimab was given to the active arm every 28 days at a dose level of 24 mg/kg (maximum dose not to exceed 2500 mg).Pat
Tue May 27, 2025
Expert Outlook: Prothena Corp Through The Eyes Of 5 Analysts. In the last three months 5 analysts have published ratings on Prothena Corp (NASDAQ:) offering a diverse range of perspectives from ish to bearish.In the table below you'.ll find a summary of their recent ratings revealing the shifting sentiments over the past 30 days and comparing them to the previous months.4100020000210000000000000Analysts provide deeper insights through their assessments of 12-month price targets revealing an
Tue May 27, 2025
Why Is Prothena Stock Trading Lower On Tuesday?.
Tue May 27, 2025
Prothena to evaluate options after phase 3 birtamimab failure. shares plunge.
Fri May 23, 2025
Prothena to evaluate options after phase 3 birtamimab failure. shares plunge.
Fri May 23, 2025
Prothena stock plummets following failed Phase 3 trial.
Fri May 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PRTA Stock trends
PRTA Stock performance
PRTA Stock analysis
PRTA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
